Extended intervention time and evaluation of sperm suppression by dienogest plus testosterone undecanoate in male rat
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study evaluated the effectiveness of dienogest plus testosterone undecanoate on sperm suppression in male rats following an extended intervention period.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BackgroundThe potential of using dienogest [DNG, 40 mg/kg body weight (bw)] plus testosterone undecanoate (TU, 25 mg/kg bw) in rats for development of a once-a-month male hormonal contraceptive has been reported earlier in our laboratories.Study designIn the present study, we report a separate efficacy evaluation of the same combination, DNG (40 mg/kg bw) and TU (25 mg/kg bw) in which interval of drug administration has been extended further to 45 and 60 days instead of every 30 days.ResultsComplete sperm suppression was observed in rats sacrificed either 60 or 90 days after DNG+TU administration, for two injections at 45-day interval. The neutral α-glucosidase activity in these treated rats remained in the normal range. Germ cell loss due to apoptosis was frequently observed both after 60 or 90 days of combination treatment. Significant decline in serum gonadotropin and testosterone, both serum and intratesticular levels, were observed in the treated rats. Following stoppage of treatment (given at 45-day interval) after two (0 and 45 days) or three injections (0, 45 and 90 days), complete restoration of spermatogenesis was observed by 120 and 165 days, respectively. The sperm suppression, however, could not be sustained when the period of combined drug administration was extended from every 45 to 60 days.ConclusionsDienogest plus testosterone undecanoate in the above doses retained contraceptive effectiveness when administered every 45 days but not 60 days. The spermatogenic arrest was completely reversible once drug treatment is stopped. The dose and the frequency of intervention can be extrapolated in future clinical trials.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men 2002
- Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats 2009
Cited by (1)
References (34)
- Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats via openalex
- Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men via openalex
- doi:10.1007/s10495-005-0813-7 via openalex
- doi:10.1210/jcem.87.2.8218 via openalex
- doi:10.1002/ar.1091870307 via openalex
- doi:10.1210/jc.86.1.303 via openalex
- doi:10.1016/0010-7824(92)90161-l via openalex
- doi:10.2164/jandrol.108.006296 via openalex
- doi:10.1007/s10495-006-8761-4 via openalex
- doi:10.1210/jcem.86.1.7057 via openalex
- doi:10.1210/jcem.81.3.8772548 via openalex
- W6649169725 via openalex
- W6832919480 via openalex
- doi:10.1016/0010-7824(87)90020-5 via openalex
- doi:10.1210/jcem.87.8.8710 via openalex
- doi:10.1210/jc.2003-030574 via openalex
- doi:10.1210/jc.2002-020447 via openalex
- doi:10.1111/j.1365-2605.1990.tb01048.x via openalex
- doi:10.1093/humupd/dml010 via openalex
- doi:10.1210/endo.140.9.6958 via openalex
- doi:10.1210/jc.2003-031307 via openalex
- doi:10.1002/ar.1090940210 via openalex
- doi:10.1093/humrep/17.11.2869 via openalex
- doi:10.1002/j.1939-4640.2000.tb03272.x via openalex
- doi:10.1093/humrep/del094 via openalex
- doi:10.1210/jcem.80.8.7543113 via openalex
- doi:10.1093/humrep/15.3.637 via openalex
- doi:10.2164/jandrol.106.002345 via openalex
- doi:10.1210/jc.2002-022043 via openalex
- doi:10.1002/j.1939-4640.2002.tb02311.x via openalex
- doi:10.1210/jc.2008-1846 via openalex
- doi:10.1002/j.1939-4640.1997.tb01913.x via openalex
- doi:10.1210/endo-57-3-369 via openalex
- doi:10.1111/j.1365-2605.2003.00431.x via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-14T06:07:48.142452+00:00
- unpaywall
- last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0
· commercial use OK